跳至主要内容
临床试验/DRKS00015299
DRKS00015299已完成未知

INTACT-Lymph_Interventional approach to lymphatic leakage - INTACT-Lymph

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 100 人开始时间: 2018年11月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Existence of postoperative clinically relevant LL with indication for intervention
  • - Therapy resistance to conservative treatment options (parenteral nutrition, percutaneous drainage, middle-chain triglyceride diet)
  • - present lymph nodes / lymphatic vessels / lymphatic leak
  • - platelets> 50,000 / mm3 (50 GPt / l)
  • - PTT-INR / PTT> 1.5 times upper limit (patients taking anticoagulants may be included if no underlying blood clotting abnormality has previously been detected)
  • - Signed informed consent
  • - Age> 18 years

排除标准

  • - Severe pulmonary insufficiency
  • - Heart defect with right-left shunt
  • - Contraindications to treatment with Lipiodol
  • - contraindications to lymphography
  • - platelets <50,000 / mm3 (50 GPt / l)
  • - PTT-INR / PTT <1.5 times the upper standard value
  • - abnormality of blood clotting

研究者

发起方
Klinikum der Universität München, Campus Großhadern

相似试验